| Oct 26 |
vTv Therapeutics Faces License Agreement Termination
|
| Aug 16 |
We're Keeping An Eye On vTv Therapeutics' (NASDAQ:VTVT) Cash Burn Rate
|
| Aug 8 |
vTv Therapeutics GAAP EPS of -$0.81
|
| Aug 8 |
VTv Therapeutics: Q2 Earnings Snapshot
|
| Aug 8 |
vTv Therapeutics Announces 2024 Second Quarter Financial Results and Provides Corporate Update
|
| Jul 29 |
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
|
| Jul 29 |
FDA Puts Brake On vTv Therapeutics' Diabetes Candidate Program, Including Late-Stage Study, Stock Tanks
|
| Jul 29 |
FDA places vTv Therapeutics’s cadisegliatin programme on clinical hold
|
| Jul 29 |
Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
|
| Jul 26 |
vTv Therapeutics' Cadisegliatin Program for Type 1 Diabetes Placed on Clinical Hold; Shares Sink
|
